Miebo

Generic Name/API: Perfluorohexyloctane
Manufacturer: Bausch & Lomb Inc
Packaging: Topical Ophthalmic form
Storage: Store at 20ºC to 25ºC
Dosage: One drop, four times daily into each eye.
Strength: One drop for four times a day.
Indication: Miebo (Perfluorohexyloctane) is a prescription medication used to treat dry eye disease.
No Indian generic option is available.
 
?>

About Miebo

  • Miebo is a perfluorohexyloctane ophthalmic solution used to treat the signs and symptoms of dry eye disease. 
  • Miebo is the first and only prescription eye drop that directly targets tear evaporation, the leading cause of dry eye disease.
  • Miebo is a small, comfortable drop that spreads quickly across the eye, coating it in a protective layer. Miebo is made from only one ingredient and is both preservative and steroid-free. 
  • Miebo is an FDA-approved Rx drop that has been tested in 2 clinical studies and can only be prescribed by a doctor. It is important for patients to use Miebo exactly as prescribed. 
  • It is not known if Miebo is safe and effective in children under the age of 18.

Strength: 

Topical Ophthalmic : The ophthalmic solution consists of 100% perfluorohexyloctane.


Recommended Dosage:

Miebo is an ophthalmic solution designed to provide relief and support for various eye conditions. When using Miebo, it’s important to follow the recommended dosing instructions for optimal results and to ensure the safety of your eyes.

  • The suggested dosage is one drop of Miebo to be instilled into each eye. 
  • This should be done four times a day. It’s essential to administer the drops as evenly spaced throughout the day as possible, allowing for approximately six to eight hours between each application. 
  • This regular dosing schedule is intended to maintain a consistent level of the medication in your eyes, ensuring its effectiveness in addressing your specific eye condition.

Important

Before instilling the Miebo eye drop, it’s crucial to wash your hands thoroughly with soap and water to prevent any potential contamination. Gently shake the Miebo bottle to ensure that the solution is well-mixed. Then, using a clean and dry tissue or cloth, gently wipe any excess moisture from your eyes.

To drop the Miebo eye drop, tilt your head backward, look upward, and use one hand to pull down your lower eyelid gently, creating a small pocket. Hold the Miebo bottle with your other hand and carefully instill one drop into the pocket formed by the lower eyelid. Be cautious not to touch your eye with the dropper tip to avoid any contamination.


Warnings & Precautions

  • Miebo is contraindicated in patients with a history of known severe hypersensitivity to the components of Miebo and its ingredients. Before using perfluorohexyloctane, patients should tell their doctor or pharmacist if they are allergic to it or if they have any other allergies.
  • Miebo should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Patients should talk to their healthcare provider about the risks and benefits of Miebo during pregnancy. 
  • It is unknown whether breastfeeding women can use this medicine. Before starting the medicine, inform your doctor if you are breastfeeding. 
  • Miebo should not be administered while wearing contact lenses.
  • Patients should remove contact lenses before using Miebo and wait for at least 30 minutes before reinserting.
  • Miebo should only be used as directed by a doctor.
  • Patients should not use Miebo if they are under the age of 18.
  • Patients should not touch the dropper tip or let it touch their eye or any other surface to avoid contamination.
  • Patients should apply gentle pressure for 1 to 2 minutes before opening their eyes to prevent the medication from draining out.
  • Patients should not rinse the dropper and should replace the dropper cap after each use.
  • Patients should wait several minutes for their vision to clear before driving or operating machinery.
  • Patients should use Miebo regularly to get the most benefit from it and tell their doctor if their condition lasts or gets worse.

Common Miebo Side Effects:

  • Blurred vision
  • Eye redness
  • Allergic reactions
  • Eye pain
  • Swelling of the eye
  • Vision changes
  • Sensitivity to light

Use in Specific Population

  • Miebo’s safety and effectiveness have not been established for patients under 18 years of age. However, there have been no discernible variations in safety and effectiveness between older and younger patients.

Storage and Handling

  • Keep Miebo at temperatures between 20ºC to 25ºC (68ºF to 77ºF). Once opened, Miebo remains usable until the bottle’s expiration date.
  • Miebo (perfluorohexyloctane ophthalmic solution) is provided in 5 mL polypropylene bottles with dropper tips and screw caps, enclosed in a carton, maintaining its sterility as a clear and colorless liquid.

Sansfro follows a simple four-step protocol for medication procurement to ensure that patients can access the prescription drugs they need:

  1. Medication Inquiry: The Sansfro Named Access Programme Support team responds to patient inquiries regarding medication information, processing their details, and reaching out to provide assistance within 24 hours.
  2. Verification Process: To help patients obtain medications that may not be authorized or readily available in their home countries, Sansfro ensures verification of medicine availability and approval. They also meticulously review the patient’s prescription and medical records for accuracy and compliance.
  3. Medication Procurement: Once the patient successfully clears the verification process, Sansfro’s team contacts their network of suppliers to procure the required medication. They oversee the order processing and work diligently to secure competitive prices for the medicines.
  4. Secure Delivery: Once the final quote is approved, Sansfro coordinates the safe delivery of the consignment. Their team of logistics experts provides shipment tracking support, and Sansfro strictly adheres to Standard Operating Procedures to ensure the safe and legal distribution of pharmaceuticals.

The Sansfro team will start In order to import medication, patients need to provide the following paperwork:

  1. A copy of a valid prescription.
  2. A Document confirming their identity.
  3. Information about the medical professional who wrote the prescription.
  4. Current home address.

As soon as these documents are received, the Sansfro team will begin the import licence application process. This licence is a crucial prerequisite for getting the required medication after gaining government approval.

No news found.

About Sansfro

Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.

Know More...

FAQ'S

Is there any specific patient counseling information for Miebo?

Patients should be advised to remove contact lenses before using Miebo and wait for at least 30 minutes after administration before reinserting them. The administration instructions should be followed carefully for proper usage.

Is Miebo carcinogenic or mutagenic?

Long-term studies in animals have not been conducted to evaluate the carcinogenic potential of perfluorohexyloctane. Perfluorohexyloctane was not found to be mutagenic or clastogenic in various genotoxicity tests.

What is the mechanism of action for Miebo in treating dry eye disease (DED)?

While the exact mechanism of action for Miebo in treating DED is not known, it is believed that perfluorohexyloctane forms a monolayer at the air-liquid interface of the tear film, which can be expected to reduce evaporation.

Is perfluorohexyloctane safe for use in children?

The safety and effectiveness of perfluorohexyloctane eye drop in pediatric patients below the age of 18 years have not been established.

Can I use perfluorohexyloctane while breastfeeding?

The presence of perfluorohexyloctane in human milk and its effects on the breastfed infant are not known. It’s essential to weigh the potential benefits of breastfeeding against the clinical need for Miebo, taking into account the lack of clinical data during lactation.

What is the Miebo cost in India?

The price of Miebo cost in India is determined by individual product requirements. For further details, please contact our Patient Support Team at ‎(+91) 93157 05373 or via email at help@sansfro.com

How to Buy Miebo online?

As Miebo is exclusively available in the US and EU markets, individuals residing outside these regions must initiate the import process. Patients or their family members should contact an authorized pharmaceutical company to inquire about the availability and pricing of the medication.

Dr Anchal Aryan

Medical counselor

Patient Support Head Detail

Dr Anchal Aryan

Medical counselor

COTACT US NOW

Patient Stories

Great Customer support
Invimeds Health boasts an exceptional team that consistently provides excellent customer service. We extend our gratitude to Sachin.
Aamir Hussain
Leqembi for Grand father
Invimeds helped me for providing my grand father LEQEMBI for Alzheimers in far flung area of Uttarkhand.
Shivam Pandit
Thankyou Invimeds
Thank you Invimeds team for providing Zejula for my grand mother at earliest. This has helped us a lot to go ahead with her cancer treatment.
Satrudhan Shukla

Word Wide Delivery:

India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.

×